212 related articles for article (PubMed ID: 17390144)
1. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W; Aiello F
Int J Colorectal Dis; 2007 Sep; 22(9):1103-8. PubMed ID: 17390144
[TBL] [Abstract][Full Text] [Related]
2. Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon.
Tursi A
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S119-22. PubMed ID: 18806701
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
Tursi A; Brandimarte G; Daffinà R
Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
[TBL] [Abstract][Full Text] [Related]
4. Balsalazide in treating colonic diseases.
Tursi A
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1555-63. PubMed ID: 19708827
[TBL] [Abstract][Full Text] [Related]
5. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
J Clin Gastroenterol; 2006 Apr; 40(4):312-6. PubMed ID: 16633103
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
Stollman N; Magowan S; Shanahan F; Quigley EM;
J Clin Gastroenterol; 2013 Aug; 47(7):621-9. PubMed ID: 23426454
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
Hepatogastroenterology; 2008; 55(84):916-20. PubMed ID: 18705297
[TBL] [Abstract][Full Text] [Related]
10. Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study.
Tursi A; Di Mario F; Brandimarte G; Elisei W; Picchio M; Loperfido S; Dal Bo' N; Ferrara F; Marcello R; Heras Salvat H; Scarpignato C
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3244-8. PubMed ID: 24338468
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
13. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
[TBL] [Abstract][Full Text] [Related]
15. Acute diverticulitis of the colon--current medical therapeutic management.
Tursi A
Expert Opin Pharmacother; 2004 Jan; 5(1):55-9. PubMed ID: 14680435
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
17. Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.
Wiggins JB; Rajapakse R
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1279-84. PubMed ID: 19743890
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.
Rahimi R; Nikfar S; Rezaie A; Abdollahi M
Dig Dis Sci; 2009 Apr; 54(4):712-21. PubMed ID: 18683049
[TBL] [Abstract][Full Text] [Related]
19. Mesalazine for diverticular disease of the colon--a new role for an old drug.
Tursi A
Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Tursi A; Brandimarte G; Papa A; Giglio A; Elisei W; Giorgetti GM; Forti G; Morini S; Hassan C; Pistoia MA; Modeo ME; Rodino' S; D'Amico T; Sebkova L; Sacca' N; Di Giulio E; Luzza F; Imeneo M; Larussa T; Di Rosa S; Annese V; Danese S; Gasbarrini A
Am J Gastroenterol; 2010 Oct; 105(10):2218-27. PubMed ID: 20517305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
